Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on N (4 isobutoxybenzyl)carbamic acid ester. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN110894186B details a safe, high-yield route for pimavanserin intermediates using carbon dioxide, eliminating toxic phosgene and reducing impurities for cost-effective manufacturing.